Literature DB >> 33387489

Considering benefit and risk before routinely recommending SpaceOAR.

William A Hall1, Alison C Tree2, David Dearnaley2, Christopher C Parker2, Vinay Prasad3, Mack Roach4, Colleen A F Lawton5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33387489      PMCID： PMC8882263          DOI： 10.1016/S1470-2045(20)30639-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  How to spot bias and other potential problems in randomised controlled trials.

Authors:  S C Lewis; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

2.  Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database.

Authors:  Alireza Aminsharifi; Srinath Kotamarti; David Silver; Ariel Schulman
Journal:  J Endourol       Date:  2019-09-27       Impact factor: 2.942

Review 3.  Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors.

Authors:  Asbjørn Hróbjartsson; Ann Sofia Skou Thomsen; Frida Emanuelsson; Britta Tendal; Jørgen Hilden; Isabelle Boutron; Philippe Ravaud; Stig Brorson
Journal:  CMAJ       Date:  2013-01-28       Impact factor: 8.262

4.  Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

Authors:  Neil Mariados; John Sylvester; Dhiren Shah; Lawrence Karsh; Richard Hudes; David Beyer; Steven Kurtzman; Jeffrey Bogart; R Alex Hsi; Michael Kos; Rodney Ellis; Mark Logsdon; Shawn Zimberg; Kevin Forsythe; Hong Zhang; Edward Soffen; Patrick Francke; Constantine Mantz; Peter Rossi; Theodore DeWeese; Daniel A Hamstra; Walter Bosch; Hiram Gay; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-23       Impact factor: 7.038

5.  Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.

Authors:  Daniel A Hamstra; Neil Mariados; John Sylvester; Dhiren Shah; Lawrence Karsh; Richard Hudes; David Beyer; Steven Kurtzman; Jeffrey Bogart; R Alex Hsi; Michael Kos; Rodney Ellis; Mark Logsdon; Shawn Zimberg; Kevin Forsythe; Hong Zhang; Edward Soffen; Patrick Francke; Constantine Mantz; Peter Rossi; Theodore DeWeese; Stephanie Daignault-Newton; Benjamin W Fischer-Valuck; Anupama Chundury; Hiram Gay; Walter Bosch; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-23       Impact factor: 7.038

6.  Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.

Authors:  Jeff M Michalski; Jennifer Moughan; James Purdy; Walter Bosch; Deborah W Bruner; Jean-Paul Bahary; Harold Lau; Marie Duclos; Matthew Parliament; Gerard Morton; Daniel Hamstra; Michael Seider; Michael I Lock; Malti Patel; Hiram Gay; Eric Vigneault; Kathryn Winter; Howard Sandler
Journal:  JAMA Oncol       Date:  2018-06-14       Impact factor: 31.777

7.  Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.

Authors:  Joseph F Levy; Rahul Khairnar; Alexander V Louie; Timothy N Showalter; C Daniel Mullins; Mark V Mishra
Journal:  Pract Radiat Oncol       Date:  2018-10-17

8.  Re: Aminsharifi et al., Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database (From: Aminsharifi A, Kotamarti S, Silver D, et al., J Endourol 2019;33:868-871; DOI: 10.1089/end.2019.0431).

Authors:  Richard K Babayan; Michael L Steinberg; Larry E Miller
Journal:  J Endourol       Date:  2020-02       Impact factor: 2.942

9.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Authors:  David Dearnaley; Isabel Syndikus; Helen Mossop; Vincent Khoo; Alison Birtle; David Bloomfield; John Graham; Peter Kirkbride; John Logue; Zafar Malik; Julian Money-Kyrle; Joe M O'Sullivan; Miguel Panades; Chris Parker; Helen Patterson; Christopher Scrase; John Staffurth; Andrew Stockdale; Jean Tremlett; Margaret Bidmead; Helen Mayles; Olivia Naismith; Chris South; Annie Gao; Clare Cruickshank; Shama Hassan; Julia Pugh; Clare Griffin; Emma Hall
Journal:  Lancet Oncol       Date:  2016-06-20       Impact factor: 41.316
  9 in total
  7 in total

1.  Clinical Outcomes of Hydrogel Spacer Injection Space OAR in Men Submitted to Hypofractionated Radiotherapy for Prostate Cancer.

Authors:  Pietro Pepe; Maria Tamburo; Michele Pennisi; Dario Marletta; Francesco Marletta
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

2.  Case Report: Role of an Iodinated Rectal Hydrogel Spacer, SpaceOAR Vue™, in the Context of Low-Dose-Rate Prostate Brachytherapy, for Enhanced Post-Operative Contouring to Aid in Accurate Implant Evaluation and Dosimetry.

Authors:  Andrew Gross; Jiankui Yuan; Daniel Spratt; Elisha Fredman
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

3.  Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.

Authors:  Subaru Sawayanagi; Hideomi Yamashita; Mami Ogita; Ryosuke Takenaka; Yuki Nozawa; Yuichi Watanabe; Toshikazu Imae; Osamu Abe
Journal:  Radiat Oncol       Date:  2022-02-23       Impact factor: 3.481

4.  Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel.

Authors:  Palak Kundu; Eric Y Lin; Stephanie M Yoon; Neil R Parikh; Dan Ruan; Amar U Kishan; Alan Lee; Michael L Steinberg; Albert J Chang
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

Review 5.  Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.

Authors:  Michael C Repka; Michael Creswell; Jonathan W Lischalk; Michael Carrasquilla; Matthew Forsthoefel; Jacqueline Lee; Siyuan Lei; Nima Aghdam; Shaan Kataria; Olusola Obayomi-Davies; Brian T Collins; Simeng Suy; Ryan A Hankins; Sean P Collins
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

6.  Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.

Authors:  Rosario Mazzola; Gianluisa Sicignano; Francesco Cuccia; Claudio Vitale; Michele Rigo; Niccolò Giaj-Levra; Luca Nicosia; Vanessa Figlia; Francesco Ricchetti; Giorgio Attinà; Edoardo Pastorello; Antonio De Simone; Davide Gurrera; Stefania Naccarato; Ruggero Ruggieri; Filippo Alongi
Journal:  Br J Radiol       Date:  2021-07-20       Impact factor: 3.629

Review 7.  Practical considerations for prostate hypofractionation in the developing world.

Authors:  Michael Yan; Andre G Gouveia; Fabio L Cury; Nikitha Moideen; Vanessa F Bratti; Horacio Patrocinio; Alejandro Berlin; Lucas C Mendez; Fabio Y Moraes
Journal:  Nat Rev Urol       Date:  2021-08-13       Impact factor: 14.432
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.